MSG Maschinenbau GmbH v. EJP Maschinen GmbH

UPC-001213

This case concerned an infringement action and a counterclaim for revocation regarding European Patent EP 3 225 320 B1, which relates to a device and method for measuring the straightness of rod-shaped workpieces. Following the complete revocation of the patent by the EPO Board of Appeal on July 4, 2024, the plaintiff withdrew the infringement action under Rule 265 RoP and sought a 60% reimbursement of court fees. The defendant sought a declaration that the revocation counterclaim had become moot under Rule 360 RoP and also requested a 60% reimbursement of court fees.

Jurisdiction
European UPC
Court
Munich (DE) Local Division
Case Number
UPC-001213
Judge(s)
INNEN Diese Entscheidung wurde durch die Vorsitzende Richterin Ulrike Vo; in Mjoca Mlakar erlassen

Detailed Summary

The plaintiff, MSG Maschinenbau GmbH, is the proprietor of European Patent EP 3 225 320 B1, which concerns a device and method for measuring the straightness of rod-shaped workpieces. The defendant, EJP Maschinen GmbH, manufactures, offers, and distributes in Germany devices for measuring the straightness of rod-shaped products under the designations "Straightness Control Type TQC" (accused embodiment 1) and "Total Quality Control Type TQC 2.0" (accused embodiment 2). The plaintiff filed an infringement action seeking injunctive relief, information, disclosure of accounts, destruction, recall, cost coverage for publication of the judgment, and damages or a determination of damages. The defendant denied infringement and filed a counterclaim for revocation of the patent, to which the plaintiff responded with auxiliary requests for amendment of the patent.

The EPO Board of Appeal revoked the patent in its entirety during oral proceedings on July 4, 2024 (case T-0367/23-3.4.02). Following this legally effective revocation, the plaintiff considered its infringement action to have lost its basis and sought to withdraw the action pursuant to Rule 265.1 RoP. Since the written proceedings had not yet been concluded, the plaintiff additionally sought reimbursement of 60% of the court fees pursuant to Rule 370.9(b)(i) RoP. In the event that the defendant did not withdraw the revocation counterclaim, the plaintiff declared its consent to a declaration of mootness under Rule 360 RoP. The defendant stated that it did not assert a legitimate interest within the meaning of Rule 265.1 sentence 3 RoP. Regarding the revocation counterclaim, the defendant sought a declaration under Rule 360 RoP that the counterclaim had become moot due to the revocation of the patent. The defendant also sought reimbursement of 60% of the court fees for the counterclaim pursuant to Rule 370.9(b)(i) RoP and Rule 370.9(c)(i) RoP applied analogously.

& Analysis: The court addressed the procedural consequences of the patent's revocation by the EPO Board of Appeal. The withdrawal of the infringement action under Rule 265 RoP and the request for a declaration of mootness regarding the revocation counterclaim under Rule 360 RoP were both grounded in the fact that the patent had been revoked in its entirety, eliminating the legal basis for both proceedings. The reimbursement requests for 60% of the court fees were based on the fact that the written proceedings had not yet been concluded.

Final Order & Ruling: The court was asked to grant the withdrawal of the infringement action under Rule 265 RoP, order reimbursement of court fees in the amount of 60%, and address the defendant's requests regarding the revocation counterclaim, including the declaration of mootness and reimbursement of court fees.

Practitioner Note

This case demonstrates the evidentiary and procedural standards applied in patent matters before Munich (DE) Local Division. Understanding the court's reasoning in MSG Maschinenbau GmbH vs EJP Maschinen GmbH is valuable context for structuring arguments or assessing risk in similar proceedings.

Related Cases

patentUPC-001504

Progress Maschinen & Automation AGvsRespondent

The Court of Appeal of the Unified Patent Court granted suspensive effect to an appeal filed by Progress Maschinen & Automation AG against an order of the Local Division Milan that revoked provisional measures to preserve evidence and inspect premises, and ordered the restitution of gathered evidence to the respondents. The Court held that enforcement of the restitution order pending the appeal would render the appeal largely ineffective, as the return of evidence would be difficult to reverse if the appeal succeeded.

patentUPC_8F92ACD828

BMS Innovations, LLCvsBYD Company Ltd et al

The Court of First Instance of the Unified Patent Court (The Hague Local Division) ruled on BYD's application under Rule 158 RoP for security for costs in an infringement action concerning EP3393001. The court ordered BMS Innovations, LLC (BMSI) to provide security of EUR 350,000 for BYD's legal costs and expenses, to be furnished within four weeks of service of the order, failing which a default decision may be issued under Rule 355 RoP.

patentUPC-000130

ZTE CorporationvsSamsung Electronics Co., Ltd. et. al.

This order from the Mannheim Local Division concerns procedural requests in an infringement action relating to European patent EP 3 905 730. Samsung sought to produce a third-party licence agreement and to extend the written procedure under R. 36 RoP to respond to ZTE's newly raised arguments regarding a published rate in the FRAND counterclaim context. The court rejected the request to extend the written procedure, provisionally permitted Samsung to respond in the interim procedure, ordered production of the licence agreement subject to confidentiality protections under R. 262A RoP, and closed the written procedure.

patentUPC-000358

Sanofi-Aventis GmbH, Sanofi A/S, Sanofi Mature IP, Sanofi-Aventis France, Sanofi B.V., Sanofi - Produtos Farmaceuticos Lda, Sanofi Winthrop Industrie, Sanofi AB, Sanofi-Aventis Deutschland GmbH, Sanofi S.r.l., Sanofi BelgiumvsZentiva Pharma GmbH, Zentiva France, Zentiva, k.s.

This is a procedural order issued by the Local Division Munich of the Court of First Instance on 15 September 2025, following the second interim conference in four consolidated infringement actions concerning European patent EP 2 493 466. The claimants are multiple Sanofi entities, and the defendants are generic pharmaceutical companies from four groups: Accord Healthcare, STADA, Reddy Pharma, and Zentiva. The order addresses procedural matters including the status of the EPO Board of Appeal decision, expert testimony arrangements, the schedule for the oral hearing scheduled for 14–17 October 2025, and rulings on the admissibility of late-filed evidence.

patentUPC-000522

Visibly Inc.vsRespondent

Visibly Inc. appealed an order of the Hamburg Local Division concerning security for legal costs in its patent infringement action against Easee. After the proceedings were stayed due to insolvency proceedings against the Easee companies, Visibly applied to withdraw the appeal citing an out-of-court settlement, to which Easee consented. The Court of Appeal permitted the withdrawal, declared the proceedings closed, and ordered reimbursement of 60% of the appeal court fees to Visibly.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call